news head

June 16, 2014

Cancer screening company Nucleix raises $5m

Orbimed Israel and Zohar Zisapel participated in the financing round. Nucleix, which is developing a test for early detection of bladder cancer, has raised more than $5 million in an investment round led by venture capital firm OrbiMed Advisors LLC.

read more >